Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

Terminated

• Conditions: Sperm DNA Impact on ART Outcomes

• Registration Number: NCT00875095
• Lead Sponsor: Northwell Health

Brief Summary

The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10
• Primary Completion: 2008-12
• Study Completion: 2008-12
• Study First Submitted: 2009-04-02
• Study First Submitted QC: 2009-04-02
• Study First Posted: 2009-04-03
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-07
• Last Update Posted: 2016-09-08

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Male
• Target Recruitment: 8

Inclusion Criteria

• needs interventions through artificial reproductive treatment to achieve a pregnancy

Exclusion Criteria

• severly oligozoospermic patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sperm DNA integrity	1 day

Secondary Outcome Measures

Name	Time	Method
achievement of a successful pregnancy	1 year

Trial Locations

Locations (1)

The Center for Human Reproduction; 🇺🇸 Manhasset, New York, United States